Last reviewed · How we verify
Xuanhuang Runtong Tablet Simulator — Competitive Intelligence Brief
phase 3
Traditional Chinese Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Xuanhuang Runtong Tablet Simulator (Xuanhuang Runtong Tablet Simulator) — Beijing Hospital of Traditional Chinese Medicine. Xuanhuang Runtong Tablet Simulator is a traditional Chinese medicine that is believed to have anti-inflammatory and immunomodulatory effects.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Xuanhuang Runtong Tablet Simulator TARGET | Xuanhuang Runtong Tablet Simulator | Beijing Hospital of Traditional Chinese Medicine | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Xuanhuang Runtong Tablet Simulator CI watch — RSS
- Xuanhuang Runtong Tablet Simulator CI watch — Atom
- Xuanhuang Runtong Tablet Simulator CI watch — JSON
- Xuanhuang Runtong Tablet Simulator alone — RSS
Cite this brief
Drug Landscape (2026). Xuanhuang Runtong Tablet Simulator — Competitive Intelligence Brief. https://druglandscape.com/ci/xuanhuang-runtong-tablet-simulator. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab